You are here

P&T® Journal contents for October 2002


Replacement of hormones after menopause can be tricky for women who already have heart disease.
Kimberly Braxton Lloyd, PharmD, Kirsten Fanning, PharmD, CGP, and Lisa Boothby, PharmD
The authors summarize new strategies for preventing and treating stroke in older patients.
Charles T. Taylor, PharmD, BCPS, Pamela Stamm, PharmD, Kelly H. Taylor, PharmD, and Kristi Kelley, PharmD
Several new treatment options are available for men with prostate cancer.
Kirsten D. Fanning, PharmD, CGP, and Kimberly Braxton Lloyd, PharmD
Bisphosphonates play an important role in the treatment of osteoporosis.
Lisa Anne Boothby, PharmD
The authors present a comprehensive review of Alzheimer’s disease and related dementias.
Michael Lewko, MD, CMD, Elyas Safar, MD, and Richard Birrer, MD, MPH, FACP, FAGS


Editor-in-Chief David Nash discusses how technology may soon revolutionize a patient’s hospital experience.
David B. Nash, MD, MBA
Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Prescription Washington
Mr. Barlas discusses the Senate’s perceptions of problems with PBMs.
Stephen Barlas
Medication Errors
Professionals who prescribe medications must understand the “five rights.”
Matthew Grissinger
Drug Forecast
The authors review the latest triptan (frovatriptan) for the treatment of acute migraine.
Evans Branch III, PharmD, Marlon Honeywell, PharmD, Erika Slater, Pharm D Candidate, Daryl Norwood, PharmD, and Letitia Coleman, PharmD Candidate